General MedicationsORALGeneric
NOVAFED
PSEUDOEPHEDRINE HYDROCHLORIDE
Standard Dose
120MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NOVAFED is listed in Drugs@FDA under application 017603 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 120MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1996-06-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview NOVAFED is listed in Drugs@FDA under application 017603 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 120MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1996-06-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.